相关实验视频

Updated: Jun 3, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

小分子MMRi36通过向MDM2/MDM4/XIAP进行降解来诱导p53-突变淋巴瘤的亡

Rati Lama¹, Wenjie Wu¹, Cory K Mavis²

¹Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.

Frontiers in oncology

|January 7, 2025

概括

在B细胞淋巴瘤中获得的抗药性对rituximab治疗是一个主要的挑战. 这项研究确定了MDM2和MDM4上调作为抵抗机制,并引入了MMRi36,一种针对这些蛋白质的新分子,以诱导耐药淋巴瘤细胞的亡.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药物发现药物发现药物发现

背景情况:

利图西马布改善了B细胞淋巴瘤的结果,但获得的耐药性导致复发.
灵活的抗药机制,特别是在p53-突变淋巴瘤中,仍然不太清楚.
已知p53调节器的MDM2和MDM4蛋白在淋巴发育中也具有p53独立的功能.

研究的目的:

调查MDM2和MDM4在B细胞淋巴瘤中Rituximab耐药性的作用.
识别和描述针对MDM2-MDM4相互作用的小分子,以进行潜在的治疗干预.

主要方法:

对Rituximab耐药细胞中MDM2和MDM4表达的分析.
淘汰研究评估MDM2/MDM4对细胞生长的影响.
高通量查以确定MDM2-MDM4异构体的小分子抑制剂.
在体外和细胞测试评估已识别的化合物的活性和机制 (MMRi36).

主要成果:

通过转录和后转录机制,MDM2和MDM4通过p53-突变的修仙药抗性细胞上调调节.
击败MDM2或MDM4显著抑制了抗修真抗性细胞的生长.
MMRi36结合并稳定MDM2-MDM4环异构体,促进它们的蛋白质体降解.
MMRi36通过激活caspase 3/7和降解XIAP,在p53-突变淋巴瘤细胞中诱导p53-独立的亡,并显示非亡性抗淋巴瘤效应.

结论:

在B细胞淋巴瘤中,MDM2和MDM4在培养修复剂耐药性的过程中起着至关重要的作用.
MMRi36是一种新型的小分子,其向MDM2/MDM4/XIAP进行降解,诱导细胞亡,并为p53-突变,抗修仙药性淋巴瘤提供潜在的治疗策略.

关键词:

MDM2DM2 在线播放在MDM4DM4中使用.MMRi36 MMRi36 在线观看里图西马布 (Rituximab) 是一种药物.一个XIAP一个XIAP一个XIAP 灭症 (apoptosis) 是一种死亡的过程.淋巴瘤淋巴瘤是什么突变的 p53 变种

更多相关视频

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...